Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HemoCue’s point-of-care diagnostic systems are widely used globally for rapid and accurate measurement of hemoglobin and other analytes. Their products are considered industry standard in many clinical settings including primary care clinics, hospitals (including emergency departments), public health programs, blood banks, ambulatory surgery centers, and women’s health. The company has sold over 350,000 systems worldwide with more than 140 million tests performed annually across over 130 countries. Clinical results consistently demonstrate high accuracy compared to central laboratory methods.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HemoCue.